Skip to content
★ Sign in to follow
WL

Wuxi Life International Holdings Group Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$1.5BTechnology

No insider purchase over the last 90 days. The latest, by Liu Guanzhou, was filed 29 Sept 2024.

Wuxi Life International Holdings Group Ltd.: what insiders have been doing

Wuxi Life International Holdings Group Ltd. is a Technology company. Its directors and officers file their transactions with HKEX. Wuxi Life International Holdings Group Ltd. has had no insider filing for more than a year; the last one goes back to 11 October 2025.

Looking back to 2023, when coverage begins, insiders filed 1 purchase and 10 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Hanza AB and Lime Technologies AB (publ). These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.

Insider Decl.
13
Thresholds
n/a
Buy Volume
€153,013
1 ops. · all time
Sell Volume
€5M
10 ops. · all time

Who traded when

BuySale
Liu Guanzhou6 sales

Since the insiders bought

  • Filed 29 Sept 2024 · 770 days ago · €153k
    +156.7%
    Entry HK$0.30 · Close at T+365 HK$0.77

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 10,131 of 26,897 companies
57.7
score / 100
Value
35
Quality
81
FCF yld-0.9%
Earn yld0.7%
EV/EBITDA·
ROE30%
Gross mgn60%
Net mgn11%
Debt/EBITDA0.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$3.38
Analyst consensus
·
Income statement
RevenueHK$94.6M
Gross profitHK$57.2M60% margin
EBITDAHK$13.9M15% margin
Net incomeHK$10.1M14.4% margin
Valuation
PER (trailing)84.5x
P/Book17.4x
Beta0.86
Balance sheet & cash
Market capHK$1.5B
Total debtHK$8.1M
Free Cash Flow-HK$13.8M
Debt / Equity9%
Profitability & ownership
ROE29.8%
ROA13.0%
% insiders38.3%
% institutions0.0%
Last declaration on 11 October 2025
Declarations13 total
  • ▼
    DirectorExecutives
    15M HKD14HKEX
    21,350,000 shares@ HK$0.6831.3% of flowShareXHKGHKEX:DA20251011E00055
  • ●
    DirectorExecutives
    0HKEX
    219,729,750 sharesShareXHKGHKEX:DA20250921E00003
  • ▼
    DirectorExecutives
    1M HKD11HKEX
    1,500,000 shares@ HK$0.682.5% of flowShareXHKGHKEX:DA20250109E00521
  • ▼
    DirectorExecutives
    3M HKD12HKEX
    3,500,000 shares@ HK$0.726.1% of flowShareXHKGHKEX:DA20250101E00021
  • ▼
    DirectorExecutives
    5M HKD12HKEX
    7,200,000 shares@ HK$0.7012.3% of flowShareXHKGHKEX:DA20241223E00420
  • ▼
    DirectorExecutives
    7M HKD13HKEX
    10,400,000 shares@ HK$0.6315.7% of flowShareXHKGHKEX:DA20241217E00400
  • ▼
    DirectorExecutives
    4M HKD12HKEX
    6,400,000 shares@ HK$0.639.7% of flowShareXHKGHKEX:DA20241216E00374
  • ▼
    DirectorExecutives
    1M HKD11HKEX
    2,900,000 shares@ HK$0.412.9% of flowShareXHKGHKEX:DA20241127E00368
  • ▼
    DirectorExecutives
    1M HKD11HKEX
    3,580,000 shares@ HK$0.312.7% of flowShareXHKGHKEX:DA20241127E00364
  • ▼
    DirectorExecutives
    823,500 HKD11HKEX
    2,700,000 shares@ HK$0.3052.0% of flowShareXHKGHKEX:DA20241127E00363
  • ▼
    DirectorExecutives
    5M HKD12HKEX
    22,600,000 shares@ HK$0.22611.9% of flowShareXHKGHKEX:DA20241024E00401
  • ▲
    DirectorExecutives
    1M HKD11HKEX
    11,051,600 shares@ HK$0.123.0% of flowShareXHKGHKEX:DA20240929E00010
    Canonical exit: 24 Dec 2024 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    370,000,000 sharesShareXHKGHKEX:DA20230419E00021

13 of 13 declarations

About Wuxi Life International Holdings Group Ltd.

Wuxi Life International Holdings Group Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the healthcare and medical services sector. It focuses on the development and provision of innovative healthcare solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations